Newsroom
Insights into LOVE
Welcome to our newsroom where we post news, events, and financial updates.
June 29, 2022
LOVE PHARMA INC. ANNOUNCES SECOND CLOSING OF FINANCING
VANCOUVER, BC, CANADA (June 29, 2022) – LOVE Pharma Inc. (“LOVE” and or “the Company”) (CSE:LUV) (FSE: G1Q0), announces it
Read MoreJune 8, 2022
Love Pharma Inc. Announces First Closing of Financing
VANCOUVER, BC, CANADA (June 8, 2022) – LOVE Pharma Inc. (“LOVE” and or “the Company”) (CSE:LUV) (FSE: G1Q0), announces it
Read MoreMay 6, 2022
Love Pharma Inc. Announces Closing of Financing
VANCOUVER, BC, CANADA (May 6, 2022) – LOVE Pharma Inc. (“LOVE” and or “the Company”) (CSE:LUV) (FSE: G1Q0), announces it
Read MoreApril 5, 2022
Love Pharma Inc. Announces First Closing of Financing
VANCOUVER, BC, CANADA (April 5, 2022) – LOVE Pharma Inc. (“LOVE” and or “the Company”) (CSE:LUV) (FSE: G1Q0), announces it
Read MoreOctober 12, 2021
Love Pharma Inc., Announces Listing on Frankfurt Stock Exchange
VANCOUVER, BRITISH COLUMBIA, October 12, 2021 / Love Pharma Inc. (CSE: LUV) (FSE: G1Q0) (the “Company”) a specialized health and
Read MoreSeptember 29, 2021
Love Pharma, Inc., Formerly Glenbriar Technologies, Inc., Announces Name Change, Consolidation, and Acquisition of Kick Pharmaceuticals, Inc.
VANCOUVER, BRITISH COLUMBIA, September 29, 2021 / Love Pharma Inc. (CSE: LUV) (the “Company”) announces that it has changed its
Read More